Welcome to My QtoA, where you can ask questions and receive answers from other members of the community.

India's Glenmark to study potential COVID-19 drug combination

0 votes

BENGALURU, playersintroduction.website2.me May 26 (Reuters) - Glenmark Pharmaceuticals Ltd said on Tuesday it will begin a new clinical trial in India to test a combination of two anti-viral drugs - favipiravir and umifenovir - as a potential COVID-19 treatment.

The study will look to enroll 158 hospitalized patients of moderate COVID-19 in India, the company added.

Last month, Glenmark said it would conduct clinical trials in India of just favipiravir as a potential treatment for COVID-19.

(Reporting by Sachin Ravikumar, Editing by Sherry Jacob-Phillips)

<!-- ad: website -->
asked Jul 2 by BerthaSpruso (100 points)

Your answer

Your name to display (optional):
Privacy: Your email address will only be used for sending these notifications.